Etonogestrel 68MG 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FBTFZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,283
Award facts
- Contract value 100% obligated
- $26,283.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $26,283.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Etonogestrel 68mg contraceptive implants. The delivery order, awarded on December 10, 2025, with an ultimate completion date of December 29, 2025, was issued under a firm fixed-price arrangement with no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. This delivery order operates under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish regional prime vendor contractors for the Department of Defense's pharmaceutical supply chain.
The PPV-G GEN V contract, awarded to DMS Pharmaceutical Group on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, encompassing a 30-month base period with three 30-month option periods. Under this framework, the Defense Logistics Agency authorizes delivery orders for a comprehensive range of pharmaceutical products—including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables—to support military healthcare facilities worldwide. DMS Pharmaceutical Group's selection as a prime vendor demonstrates its established performance capability in meeting the diverse and specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FBTFZ?
SPE2DR26FBTFZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26FBTFZ worth?
The government has obligated $26,283 on SPE2DR26FBTFZ.
Is contract SPE2DR26FBTFZ an order under another contract?
Yes. SPE2DR26FBTFZ is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTFZ competed?
The extent of competition for SPE2DR26FBTFZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award